Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Advanced or Metastatic Solid Tumor Malignancies: early-phase trial registry
2 of 2 indexed Advanced or Metastatic Solid Tumor Malignancies trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Advanced or Metastatic Solid Tumor Malignancies: 2 US clinical trials tracked, 2 recruiting.
Advanced or Metastatic Solid Tumor Malignancies is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is GigaGen, running 1 of these trials.
Enrollment posture brief
Registry condition advanced-or-metastatic-solid-tumor-malignancies
OPEN 2 | RECR 100% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Advanced or Metastatic Solid Tumor Malignancies lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Advanced or Metastatic Solid Tumor Malignancies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Advanced or Metastatic Solid Tumor Malignancies is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Novita Pharmaceuticals
NCT05023486
A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
GigaGen
NCT06258304
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Advanced or Metastatic Solid Tumor Malignancies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Advanced or Metastatic Solid Tumor Malignancies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Advanced or Metastatic Solid Tumor Malignancies page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Advanced or Metastatic Solid Tumor Malignancies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- GigaGen sponsors the most Advanced or Metastatic Solid Tumor Malignancies trials on record, review their full trial history before evaluating a specific study. See GigaGen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Advanced or Metastatic Solid Tumor Malignancies condition card totals 2 registered trials; most-linked intervention GIGA-564; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.